scispace - formally typeset
D

David G. Fernig

Researcher at University of Liverpool

Publications -  237
Citations -  14217

David G. Fernig is an academic researcher from University of Liverpool. The author has contributed to research in topics: Fibroblast growth factor & Heparan sulfate. The author has an hindex of 56, co-authored 229 publications receiving 12879 citations. Previous affiliations of David G. Fernig include Royal Liverpool University Hospital & University of Bologna.

Papers
More filters
Journal ArticleDOI

Determination of size and concentration of gold nanoparticles from UV-vis spectra

TL;DR: It is shown that the data produced here can be used to determine both size and concentration of gold nanoparticles directly from UV-vis spectra, and the precision of various methods are discussed.
Journal ArticleDOI

Rational and Combinatorial Design of Peptide Capping Ligands for Gold Nanoparticles

TL;DR: Based on protein folding considerations, a pentapeptide ligand, CALNN, which converts citrate-stabilized gold nanoparticles into extremely stable, water-solublegold nanoparticles with some chemical properties analogous to those of proteins, has been designed.
Journal ArticleDOI

A rapid method to estimate the concentration of citrate capped silver nanoparticles from UV-visible light spectra

TL;DR: A generalized table of extinction coefficient data for silver nanoparticles from 8 to 100 nm is presented, in good agreement with collated literature values measured by different authors with non-standardized methodology and each for a limited range of particle size.
Journal ArticleDOI

Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate.

TL;DR: The data indicate a primary role for contiguous sequences of IdoA(2-OSO3)alpha 1,4GlcNSO3 in mediating the high affinity binding between fibroblast HS and bFGF.
Journal ArticleDOI

Kinase-Catalyzed Modification of Gold Nanoparticles: A New Approach to Colorimetric Kinase Activity Screening

TL;DR: A simple colorimetric test to monitor kinase inhibitor activity is developed based on enzymatically biotinylated gold nanoparticles that change color from red to blue, indicating aggregation of particles.